The Pancreatic Islet Cell Antibody test identifies islet antibodies associated with pancreatic autoimmunity in type 1 diabetes (T1D) which are crucial indicators of the autoimmune response and monitored for prognosis in individuals with T1D. This test identifies risk before the onset of T1D and explores the natural history of T1D onset for appropriate management.